BDBM621818 (4S)-N-{[(R or S)-5- chloro-6-(trifluoro- methyl)pyridin-3-yl][5- fluoro-6-(trifluoro- methyl)pyridin-2- yl]methyl}-2- oxoimidazolidine-4- carboxamide::US20230312528, Example 14A

SMILES Fc1ccc(nc1C(F)(F)F)[C@@H](NC(=O)[C@@H]1CNC(=O)N1)c1cnc(c(Cl)c1)C(F)(F)F

InChI Key InChIKey=DILISHFMYZEVQO-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 621818   

TargetSodium channel protein type 8 subunit alpha(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM621818(US20230312528, Example 14A | (4S)-N-{[(R or S)-5- ...)
Affinity DataIC50: 2.40nMAssay Description:Compounds were tested on human NaV1.8 and NaV1.5 channels stably expressed in human embryo kidney (HEK) 293 cells. Sodium current measurements on Qub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/13/2023
Entry Details
Go to US Patent